Chronic Pain Industry Anticipated to Expand at 8.4% CAGR During the Forecast Period

Global Chronic Pain Market

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Chronic Pain Market From 2025 To 2034?

The chronic pain market has experienced substantial expansion in recent years. It is projected to increase from $78.79 billion in 2024 to $84.66 billion in 2025, at a compound annual growth rate (CAGR) of 7.4%. The historical expansion can be linked to aspects like injury and trauma, surgical procedures, inflammatory conditions, nerve damage and neuropathy, and the scarcity of effective treatments.

The chronic pain market is poised for significant expansion in the upcoming years, with its size projected to reach $117.03 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.4%. This anticipated growth during the forecast period is driven by factors such as an aging population, the expansion of telemedicine, increasing public health awareness, advancements in genetic research and precision medicine, and the influence of psychosocial stressors. Key trends for this period include the integration of wearable devices, the development of pain education and support groups, a shift towards holistic pain management, the adoption of non-opioid pain management strategies, and the progress of regenerative medicine for pain.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11970&type=smp

Which Industry Drivers Are Expected To Accelerate The Chronic Pain Market From 2025 To 2029?

The increasing number of individuals suffering from chronic pain is anticipated to fuel expansion in the chronic pain market. Chronic pain patients are defined as those experiencing ongoing or prolonged pain that extends past the typical recovery time or continues for more than three months. This significant occurrence of chronic pain patients propels the chronic pain market’s development, given that the rising need for successful pain management methods, such as drugs and medical equipment, fosters new advancements and growth prospects in the sector. For example, in June 2024, data from the Australian Institute of Health and Welfare, an Australia-based government body, revealed that approximately 4.0 million Australians (16% of the population) reported back problems in 2022. By 2023, back problems emerged as the third leading contributor to disease burden, accounting for 4.3% of the nation’s total. Furthermore, a February 2024 report by the Institute for Health Metrics and Evaluation, a US-based public health and research institute, indicated that worldwide neck pain cases are forecast to hit 269 million by 2050 (with a range of 219 to 322 million), marking a 32.5% rise (between 23.9% and 42.3%) from 2020 levels. Consequently, the widespread occurrence of chronic pain patients is a key factor driving the expansion of the chronic pain market.

What Are The Primary Types Of Segments Analyzed In The Chronic Pain Market?

The chronic painmarket covered in this report is segmented –

1) By Product: Drug; Devices

2) By Indication: Neuropathic Pain; Arthritis Pain; Chronic Back Pain; Cancer Pain; Migraine; Fibromyalgia; Other Indications

3) By End User: Hospitals; Clinics; Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics; Opioids; Antidepressants; Anticonvulsants; Topical Analgesics; Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units; Spinal Cord Stimulators; Intrathecal Drug Delivery Systems; Heat And Cold Therapy Devices; Bioelectronic Devices

How Are Emerging Market Trends Shaping The Chronic Pain Industry Landscape?

A significant trend emerging in the chronic pain market involves the growing adoption of alternative pain management technologies. Businesses active in the chronic pain sector are concentrating on creating cutting-edge, portable, and easy-to-use nerve stimulation devices. These devices utilize electrical impulses to stimulate nerves, thereby alleviating pain and offering a non-invasive treatment method, all aimed at maintaining their competitive edge. An illustration of this is Abbott Laboratories, a US-based healthcare firm specializing in diagnostics, medical devices, nutrition, and branded generic pharmaceuticals, which introduced Eterna in December 2022. Eterna is a sophisticated spinal cord stimulation (SCS) system, recognized as the most compact implantable and rechargeable device presently offered for chronic pain treatment. The Eterna SCS system incorporates Abbott’s proprietary low-dose BurstDR stimulation, which stands as the only waveform technology supported by comprehensive clinical evidence (1A evidence), showing a 23% higher pain reduction when contrasted with traditional waveform technology methods.

Which Industry Leaders Are Driving Innovation Across The Chronic Pain Market?

Major companies operating in the chronic pain market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Regional Markets Are Contributing Most To The Chronic Pain Industry Expansion?

North America was the largest region in the chronic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Chronic Pain Market Report:

https://www.thebusinessresearchcompany.com/customise?id=11970&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Market 2025, By The Business Research Company

Aerospace Defense Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aerospace-defense-global-market-report

Aerospace Support And Auxiliary Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aerospace-support-and-auxiliary-equipment-global-market-report

Iot In Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model